MX2009013120A - Promotor. - Google Patents

Promotor.

Info

Publication number
MX2009013120A
MX2009013120A MX2009013120A MX2009013120A MX2009013120A MX 2009013120 A MX2009013120 A MX 2009013120A MX 2009013120 A MX2009013120 A MX 2009013120A MX 2009013120 A MX2009013120 A MX 2009013120A MX 2009013120 A MX2009013120 A MX 2009013120A
Authority
MX
Mexico
Prior art keywords
seq
promoter
shortened
nucleic acid
acid sequence
Prior art date
Application number
MX2009013120A
Other languages
English (en)
Inventor
Erhard Kopetzki
Christian Klein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38476213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009013120(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009013120A publication Critical patent/MX2009013120A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Finger-Pressure Massage (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a un promotor que tiene la secuencia de ácido nucleico de la SEC ID NO:2, o SEC ID NO:03, o SEC ID NO:04, o SEC ID NO:06, la cual es un promotor SV40 acortado 1 5´, con resistencia del promotor reducida especialmente útil para la expresión limitada de los polipéptidos heterólogos o marcadores seleccionables.
MX2009013120A 2007-06-29 2008-06-25 Promotor. MX2009013120A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07012772 2007-06-29
PCT/EP2008/005135 WO2009003622A1 (en) 2007-06-29 2008-06-25 Promoter

Publications (1)

Publication Number Publication Date
MX2009013120A true MX2009013120A (es) 2010-01-15

Family

ID=38476213

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013120A MX2009013120A (es) 2007-06-29 2008-06-25 Promotor.

Country Status (15)

Country Link
US (2) US9080183B2 (es)
EP (1) EP2164972B1 (es)
JP (1) JP5108942B2 (es)
KR (1) KR101183764B1 (es)
CN (1) CN101688222B (es)
AT (1) ATE535607T1 (es)
AU (1) AU2008271658B8 (es)
BR (1) BRPI0813003A2 (es)
CA (1) CA2690475C (es)
ES (1) ES2377765T3 (es)
IL (1) IL201818A0 (es)
MX (1) MX2009013120A (es)
RU (1) RU2491344C2 (es)
TW (1) TWI352737B (es)
WO (1) WO2009003622A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130045471A1 (en) * 2011-02-25 2013-02-21 Bio-Rad Laboratories, Inc. Training system for investigations of bioengineered proteins
ES2719108T3 (es) * 2011-11-30 2019-07-08 Abbvie Biotechnology Ltd Vectores y células hospedadoras que comprenden un promotor de SV40 modificado para la expresión de proteínas
MX355624B (es) * 2011-12-22 2018-04-25 Hoffmann La Roche Combinaciones de elementos de vector de expresion, metodos novedosos de generacion de celulas de produccion y su uso para la produccion recombinante de polipeptidos.
ES2791758T3 (es) 2011-12-22 2020-11-05 Hoffmann La Roche Organización de vectores de expresión, procedimientos de generación de células de producción novedosos y su uso para la producción recombinante de polipéptidos
WO2015191508A1 (en) 2014-06-09 2015-12-17 Voyager Therapeutics, Inc. Chimeric capsids
WO2016073693A2 (en) 2014-11-05 2016-05-12 Voyager Therapeutics, Inc. Aadc polynucleotides for the treatment of parkinson's disease
SG11201703419UA (en) 2014-11-14 2017-05-30 Voyager Therapeutics Inc Modulatory polynucleotides
US10597660B2 (en) 2014-11-14 2020-03-24 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
WO2016094783A1 (en) 2014-12-12 2016-06-16 Voyager Therapeutics, Inc. Compositions and methods for the production of scaav
US11098310B2 (en) 2016-01-27 2021-08-24 Just-Evotec Biologics, Inc. Expression from transposon-based vectors and uses
US11261462B2 (en) 2016-01-27 2022-03-01 Just-Evotec Biologics, Inc. Inducible expression from transposon-based vectors and uses
JP6937309B2 (ja) 2016-01-27 2021-09-22 ジャスト−エヴォテック バイオロジックス、インコーポレイテッド ハイブリッドプロモーターおよびその使用
US11326182B2 (en) 2016-04-29 2022-05-10 Voyager Therapeutics, Inc. Compositions for the treatment of disease
WO2017189964A2 (en) 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
KR20240056729A (ko) 2016-05-18 2024-04-30 보이저 테라퓨틱스, 인크. 조절성 폴리뉴클레오티드
EP3458589A4 (en) 2016-05-18 2020-01-01 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
CN110650673B (zh) 2016-08-30 2024-04-09 加利福尼亚大学董事会 用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
US11603542B2 (en) 2017-05-05 2023-03-14 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
JP2020518259A (ja) 2017-05-05 2020-06-25 ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ハンチントン病治療組成物および方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
EP3654860A1 (en) 2017-07-17 2020-05-27 Voyager Therapeutics, Inc. Trajectory array guide system
US11512327B2 (en) 2017-08-03 2022-11-29 Voyager Therapeutics, Inc. Compositions and methods for delivery of AAV
AU2018352236A1 (en) 2017-10-16 2020-04-23 The Curators Of The University Of Missouri Treatment of amyotrophic lateral sclerosis (ALS)
US20200237799A1 (en) 2017-10-16 2020-07-30 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (als)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4411499A (en) * 1998-06-05 1999-12-20 Human Genome Sciences, Inc. Connective tissue growth factor-4
ES2353457T3 (es) * 2003-06-10 2011-03-02 Nsgene A/S Secreción mejorada de neublastina.
JP2006050956A (ja) 2004-08-11 2006-02-23 Japan Science & Technology Agency プルキンエ細胞における遺伝子の発現のための発現ベクター
US20090041783A1 (en) * 2005-04-28 2009-02-12 Mochida Pharmaceutical Co., Ltd. Anti-platelet membrane glycoprotein vi monoclonal antibody

Also Published As

Publication number Publication date
WO2009003622A8 (en) 2009-11-05
US20100159489A1 (en) 2010-06-24
AU2008271658A1 (en) 2009-01-08
CA2690475A1 (en) 2009-01-08
US9926567B2 (en) 2018-03-27
KR101183764B1 (ko) 2012-09-17
AU2008271658B8 (en) 2013-07-04
TW200914612A (en) 2009-04-01
RU2491344C2 (ru) 2013-08-27
RU2010102812A (ru) 2011-08-10
BRPI0813003A2 (pt) 2014-10-14
CN101688222B (zh) 2013-03-06
KR20100024438A (ko) 2010-03-05
ES2377765T3 (es) 2012-03-30
CN101688222A (zh) 2010-03-31
JP2010531647A (ja) 2010-09-30
AU2008271658A8 (en) 2013-07-04
EP2164972B1 (en) 2011-11-30
JP5108942B2 (ja) 2012-12-26
US20160083735A1 (en) 2016-03-24
ATE535607T1 (de) 2011-12-15
US9080183B2 (en) 2015-07-14
IL201818A0 (en) 2011-08-01
AU2008271658B2 (en) 2013-06-06
CA2690475C (en) 2014-07-29
EP2164972A1 (en) 2010-03-24
TWI352737B (en) 2011-11-21
WO2009003622A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
MX2009013120A (es) Promotor.
NZ596459A (en) Phytases, nucleic acids encoding them and methods for making and using them
BR112014019901A2 (pt) proteínas de fator viii recombinante
NI200700191A (es) Construcciones de ácido nucleico
NZ596658A (en) Dig-10 insecticidal cry toxins
HK1127085A1 (en) Variant foki cleavage half-domains
GB201009493D0 (en) Modified recombinant factor viii and von willebrand factor and methods of use
MY160995A (en) Polypeptides with permease activity
IN2014CN02050A (es)
MX2009007001A (es) Aminoacidos y polipeptidos fenazina y quinoxalina sustituidos.
WO2008146745A1 (ja) 新規なリゾホスファチジン酸アシル基転移酵素遺伝子
NZ600205A (en) Selective exosite inhibition of papp-a activity against igfbp-4
NZ597998A (en) Methods for treating cancer with mva
MX2009008877A (es) Variantes de transglutaminasa con especificidad mejorada.
NZ592464A (en) Herbicide resistant acetohydroxyacid synthase large subunit (AHAS) mutants and methods of use thereof
HK1129127A1 (en) Mcp-1 binding nucleic acids
ATE541944T1 (de) Polynukleotidprimer
WO2010129895A3 (en) Cd133 epitopes
NZ607615A (en) Antibodies directed against il-17
MX2017010359A (es) Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc).
MX2018008293A (es) Factor de von willebrand mutado.
MX346019B (es) Kit para detectar el virus de la leucemia bovina (blv), y uso del mismo.
GB0711424D0 (en) Recombinant transferrin mutants
WO2008087224A3 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
WO2008058951A8 (de) Verfahren zur enzymatischen reduktion von alkenderivaten

Legal Events

Date Code Title Description
FG Grant or registration